{
    "2019-06-21": [
        [
            {
                "time": "2018-11-15",
                "original_text": "Nordisk's Haemophilia A Drug Esperoct Gets EU Approval",
                "features": {
                    "keywords": [
                        "Nordisk",
                        "Haemophilia A",
                        "Esperoct",
                        "EU Approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-16",
                "original_text": "This Clinical Trial Didn't Work",
                "features": {
                    "keywords": [
                        "Clinical Trial",
                        "Failure"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "research"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-17",
                "original_text": "UPDATE 1-U.S. group says Novartis MS drug price out of line with benefit",
                "features": {
                    "keywords": [
                        "Novartis",
                        "MS drug",
                        "price",
                        "benefit"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-18",
                "original_text": "U.S. group says Novartis MS drug price out of line with benefit",
                "features": {
                    "keywords": [
                        "Novartis",
                        "MS drug",
                        "price",
                        "benefit"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}